TAGAYTAY CITY, Philippines – The
Philippines made history on Tuesday by being the first country in Southeast
Asia to vaccinate newborns against rota virus, earning praises from international
experts.
Dr. John Wecker, director for Vaccine Access
and Delivery of the Washington-based Path, said the inclusion of rota virus
vaccination in the Department of Health’s (DOH) Expanded Program on
Immunization (EPI) is a “good decision for the children of the Philippines.”
“The decision to introduce rota virus vaccines
requires first very clear evidence and that evidence is that we know the
vaccines work and we know these will prevent terrible disease,” said Wecker in
a press briefing on the sidelines of the 13th Asian Conference on Diarrheal
Diseases and Nutrition here.
During the conference, DOH Secretary Enrique
Ona launched the rota virus vaccination campaign that will initially benefit
some 700,000 newborns from the 5.2 million families identified as “poorest of
the poor” by the Department of Social Welfare and Development under its
National Household Targeting System (NHTS).
“The Philippines, recognizing the magnitude of
the diarrhea problem, is introducing the rota virus vaccine. P600 million has
been allotted for the procurement of the vaccines... We are looking forward to
significant gains from this move,” Ona said.
Rota virus is the virus that causes severe
diarrhea and vomiting among children below five years old. It is the second leading
killer of under-five Filipino children, accounting for 3,500 deaths annually.
Dr. Tony Nelson, a professor in the Department
of Pediatrics at the Chinese University of Hong Kong and a member of Asian
Rotavirus Surveillance Network, said the Philippines stands to set a precedent
for its neighboring countries.
“My biggest disappointment is that in Asia we
have the best data available and yet in Latin America, the rota virus vaccines
were introduced five years ago. The Philippines is the first country to use
these data (in Asia). This is a great day for the Philippines and for Asia
because many countries will follow through,” Nelson said.
According to Ona, the DOH will start the
campaign by vaccinating infants from the NHTS families who will be born from
April 2012 to April 2013.
He said the DOH has a list of these families
and that it will tap community health workers to reach out to them.
To acquire the vaccines, the DOH will call for
a bidding among vaccine manufacturers. So far, only pharmaceutical companies
Merck Sharp and Dohme (MSD) and GlaxoSmithKline (GSK) are producing the
vaccines.
The MSD vaccine is comprised of three doses
while the GSK’s is two doses, but it will cost the DOH some P900 per child for
any of the two brands. The vaccines must be initially administered among
newborns six to 12 weeks after birth while the succeeding dose is given after
four weeks.
“It is undeniable that special attention must
be given to the health of our children, particularly because many of them are
continuously and needlessly suffering from diseases that are either preventable
or treatable. Diarrhea falls among these diseases,” Ona said.
He added that if the rota virus cases will be
reduced, if not eradicated, this will contribute to the “reduction of
under-five mortality” as targeted under the Millennium Development Goals.
Sheila Crisostomo (The Philippine Star)
Business & Investment Opportunities
YourVietnamExpert is a division of Saigon Business Corporation Pte Ltd, Incorporated in Singapore since 1994. As Your Business Companion, we propose a range of services in Consulting, Investment and Management, focusing three main economic sectors: International PR; Healthcare & Wellness;and Tourism & Hospitality. We also propose Higher Education, as a bridge between educational structures and industries, by supporting international programs. Sign up with twitter to get news updates with @SaigonBusinessC. Thanks.
No comments:
Post a Comment